The Protein therapeutics market has been witnessing rapid growth on the back of the increasing prevalence of chronic diseases, such as Cancer, Diabetes, Cardiovascular diseases, and rising penetration of medical insurance. These therapies have provided innovative treatment for major diseases. Proved for their high efficiency, targeted approach to treatment, and reduced side effects, these therapies are soaring in the market, says our new research report, “Global Protein Therapeutics Market Analysis”.
Our research identified that the monoclonal antibodies form the leading segments of the global protein therapeutics industry and the segment is dominated by high ongoing innovative research. Growth in biogenerics is also expected to be high in the future and research in this segment is also promising. The global protein therapeutics market is expected to grow at a CAGR of around 13% during 2012-2014.
The main segments of the Protein therapeutics market include monoclonal antibody, Insulin, Interferon, G-CSF, and coagulation factors, amongst others. The report analyses detailed explanation of each of these segments. Various aspects, such as the market overview and size, wide range of applications, key geographical segmentation, and major players have been covered. In addition, each of these segments has been analyzed by covering the key drivers and restraints operating in them. Recent developments in the segments have been listed to cover an exhaustive overview of the specific areas that are developing in each of these sub-segments.
Our report, “Global Protein Therapeutics Market Analysis”, provides extensive information on the overview of the protein therapeutics market and presents rational and logical forecast on the performance of the sector in the future. The forecasts presented in the report are based on the correlation between the market trends and drivers. Apart from providing a detailed segmentation analysis, the report describes the emerging trends of Synthetic Biology, Drug-like Protein Therapies, improving drug delivery methodologies etc to help the reader identify key growth areas in the future. An analysis of the competitive landscape in the industry has also been covered to provide information on the development of the top players in the sector and present a holistic view to the reader. |
